A look at the day ahead in European and global markets from Stella Qiu Bond investors may have drawn some comfort from the
TOKYO (Reuters) – Japanese machine tool manufacturer Makino Milling Machine said on Wednesday that it asked Nidec to make changes to an
TOKYO (Reuters) -Japan Finance Minister Katsunobu Kato on Wednesday reiterated that the government would take appropriate action against excessive movement on the
By Kentaro Sugiyama TOKYO (Reuters) -The Bank of Japan will raise interest rates and adjust the degree of monetary support if improvements in
By Yoshifumi Takemoto TOKYO (Reuters) – Japan is likely to miss achieving its goal of running a primary budget surplus by the next
SEOUL (Reuters) – South Korea’s capital markets in December experienced the largest foreign outflows since March 2020 as heightened political uncertainty hit
(Reuters) – Euro zone households are likely to reduce their savings this year and consume more of their disposable income, though this
By Suban Abdulla LONDON (Reuters) – British inflation figures will be closely watched on Wednesday as a sharp jump in government borrowing costs,
By Rae Wee SINGAPORE (Reuters) – The dollar’s towering rally hit a speed bump on Wednesday as traders turned cautious ahead of a
Investing.com– Impeached South Korean President Yoon Suk Yeol was arrested by authorities on Wednesday following a botched attempt to impose military law
By Kantaro Komiya TOKYO (Reuters) – Japanese manufacturers’ sentiment recovered in January after a dip last month thanks to better conditions for materials
NEW YORK (Reuters) – Pfizer (NYSE:PFE) on Tuesday appealed a federal judge’s refusal to award the drugmaker $75.2 million from
SEOUL (Reuters) – South Korea’s import prices accelerated in December at the fastest pace in five months, central bank data showed on
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. A pause in the global bond selloff took some wind
By Ryan Patrick Jones (Reuters) – Canadian Prime Minister Justin Trudeau will hold a cabinet retreat on Jan. 20-21 focused on defending his
By Deena Beasley SAN FRANCISCO (Reuters) – The biopharmaceutical industry is aiming for a 2025 reversal of last year’s slump in investor returns
